Filing Details

Accession Number:
0001209191-20-065424
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-12-30 06:00:12
Reporting Period:
2020-12-29
Accepted Time:
2020-12-30 06:00:12
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1394319 Tracon Pharmaceuticals Inc. TCON () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1236540 C Mark Wiggins C/O Tracon Pharmaceuticals, Inc.
4350 La Jolla Village Drive
San Diego CA 92122
Chief Business Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-12-29 997 $10.57 13,697 No 4 P Direct
Common Stock Acquisiton 2020-12-29 3 $10.56 13,700 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
Footnotes
  1. Includes 350 shares acquired by the reporting person under the Issuer's 2015 Employee Stock Purchase Plan on October 20, 2020.